Skip to content
Business
Prognosis

Pfizer’s Covid Pill Wins FDA Emergency-Use Authorization

  • Pill reduces hospitalizations 88% when used soon after illness
  • Similar treatment from Merck is also poised for clearance
Bloomberg business news
Stamford's Dr. Asha Shah on Pfizer Pill, Omicron Fight
Updated on

Pfizer Inc.’s Covid-19 pill gained clearance for emergency use in the U.S., delivering a more convenient treatment option for at-risk patients at a critical point in the pandemic.

The drug, called Paxlovid, is the first at-home therapy for Covid-19 to win clearance from the Food and Drug Administration. It is expected to become a potent weapon in battling the virus once production gears up, giving people at high risk of severe complications from the disease a way to avoid winding up in the hospital.